|
Nov 9
|
Medicare drug price negotiations: AstraZeneca CEO's take
|
|
Nov 9
|
AstraZeneca Is Making A $2 Billion Bet To Rival Lilly, Novo In Obesity Drugs
|
|
Nov 9
|
The battle for weight loss drug dominance is heating up. Here's why.
|
|
Nov 9
|
Petrol garages under fire over rising margins at the pump
|
|
Nov 9
|
AstraZeneca bets on weight-loss pill to compete with wave of new ‘miracle’ jabs
|
|
Nov 9
|
AstraZeneca Strikes a Deal for an Experimental Weight-Loss Drug and Boosts Its Guidance
|
|
Nov 9
|
AstraZeneca CFO: Obesity Market Has a Lot of Potential
|
|
Nov 9
|
Jobless Claims Decreased More Than Expected
|
|
Nov 9
|
AstraZeneca Is Getting Into the Weight-Loss Drug Game. The Stock Needs a Boost.
|
|
Nov 9
|
Pre-Markets Strong on Higher Bond Rates, Mixed Earnings
|
|
Nov 9
|
Astrazeneca (AZN) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
|
|
Nov 9
|
Midday movers: Walt Disney, Lyft, Tesla and more
|
|
Nov 9
|
Father with brain injury sues pharma giant over Covid vaccine ‘defect’
|
|
Nov 6
|
AstraZeneca (AZN) to Report Q3 Earnings: What's in the Cards?
|
|
Nov 6
|
Pharma Stocks Are Bleeding. But These 2 Look Like Bargains.
|
|
Nov 6
|
Unlocking Q3 Potential of Astrazeneca (AZN): Exploring Wall Street Estimates for Key Metrics
|
|
Nov 5
|
12 Best Large Cap Stocks To Buy Now
|
|
Nov 3
|
Zibotentan/dapagliflozin combination demonstrated significant albuminuria reduction in patients with chronic kidney disease and proteinuria in ZENITH-CKD Phase IIb trial
|
|
Nov 3
|
Q3 2023 Ionis Pharmaceuticals Inc Earnings Call
|
|
Nov 2
|
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
|